Hims vs IVY RX: Prices, Programs & Reviews (2026)
Side-by-side comparison updated for 2026. ClearScores, pricing, medications, and ratings compared.
Hims starts at $199/mo and IVY RX at $197/mo. Hims scores higher on our ClearScore (80 vs 69), and IVY RX is the cheaper starting option.
Quick Verdict
Hims has the higher ClearScore (80 vs 69)
IVY RX is more affordable ($197/mo vs $199/mo)
Hims has higher ratings (4.5/5 vs 3.8/5)
IVY RX scores better on value (4.3/5 vs 4.2/5)
Hims
$199/mo
starting price
Polished telehealth platform with compounded semaglutide, great app experience, and strong brand reputation.
IVY RX
$197/mo
starting price
Flat-rate GLP-1 pricing that does not increase with dose. Semaglutide from $175/mo. Pharmacist-founded, 200K+ members.
Hims vs IVY RX: Full Comparison
| Hims | IVY RX | |
|---|---|---|
| ClearScore | 80/100 ✓ | 69/100 |
| Overall Rating | 4.5/5 ✓ | 3.8/5 |
| Review Count | 203 ✓ | 67 |
| Starting Price | $199/mo | $197/mo ✓ |
| Medications | Compounded Semaglutide | Compounded Semaglutide, Compounded Tirzepatide ✓ |
| Telehealth | Yes | Yes |
| Insurance | Not accepted | Not accepted |
| HSA/FSA | Accepted | Accepted |
| Founded | 2017 | 2023 |
| States Served | All 50 states | All 50 states |
Programs & Pricing
Hims Programs
GLP-1 Weight Loss
$199/mo
Medications: Compounded Semaglutide
- Medication
- Clinician Support
- Progress Tracking
- Free Shipping
IVY RX Programs
Semaglutide Program
$175-197/mo
Medications: Compounded Semaglutide
- Medication
- Consultation
- Shipping
- Supplies
Tirzepatide Program
$275-297/mo
Medications: Compounded Tirzepatide
- Medication
- Consultation
- Shipping
- Supplies
Ratings Breakdown
| Category | Hims | IVY RX |
|---|---|---|
| Overall | | |
| Value | | |
| Ease of Use | | |
| Support | | |
| Medication Quality | | |
| Results | | |
The Bottom Line
Hims edges out IVY RX with a ClearScore of 80 vs 69. IVY RX is more affordable starting at $197/mo compared to $199/mo. For customer support, Hims rates higher (4.4/5). The best choice depends on your priorities, medication preferences, and budget.